Enhanced preattentive central nervous system reactivity in irritable bowel syndrome

American Journal of Gastroenterology

Volumn 97, Issue 11, 2002, Pages 2791-2797

  Berman, Steven M ^a,b   Naliboff, Bruce D ^a,d   Chang, Lin ^a,d   FitzGerald, Leah ^a   Antolin, Tim ^b   Camplone, Art ^b   Mayer, Emeran A ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANXIETY DISORDER; ARTICLE; ATTENTION; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; EVENT RELATED POTENTIAL; EVOKED AUDITORY RESPONSE; EXTRAVERSION; FEMALE; FUNCTIONAL DISEASE; HABITUATION; HUMAN; IRRITABLE COLON; MALE; NEUROANATOMY; PITCH; PRIORITY JOURNAL; PSYCHOMETRY; SCALP; TASK PERFORMANCE;

ACOUSTIC STIMULATION; ADULT; ATTENTION; AWARENESS; BRAIN; CASE-CONTROL STUDIES; COLONIC DISEASES, FUNCTIONAL; EVOKED POTENTIALS, AUDITORY; EVOKED POTENTIALS, VISUAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOTIC STIMULATION; PSYCHOMETRICS;

EID: 0036840325     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(02)05441-2     Document Type: Article

References (41)

1. ROME II. The functional gastrointestinal disorders. Diagnosis, Pathophysiology and Treatment: A Multinational Consensus. 2nd Ed. McLean, VA: Degnon Associates, 2000.
2. Mayer EA. Emerging disease model for functional gastrointestinal disorders. Am J Med 1999;107:12S-9S.
3. Naliboff BD, Munakata J, Fullerton S, et al. Evidence for two distinct perceptual alterations in irritable bowel syndrome. Gut 1997;41:505-12.
4. Naliboff BD, Munakata J, Chang L, et al. Toward a biobehavioral model of visceral hypersensitivity in irritable bowel syndrome. J Psychosom Res 1998;45:485-92.
5. Ambrosini A, De Pasqua V, Áfra J, et al. Reduced gating of middle-latency auditory evoked potentials (P50) in migraine patients: Another indication of abnormal sensory processing? Neurosci Lett 2001;306:132-4.
6. Neylan TC, Fletcher DJ, Lenoci M, et al. Sensory gating in chronic post-traumatic stress disorder: Reduced auditory P50 suppression in combat veterans. Biol Psychiatry 1999;46:1656-64.
7. Näätenän R. Attention and Brain Function. Hillsdale, NJ. Lawrence Erlbaum Associates, 1992.
8. Cardenas VA, McCallin K, Hopkins R, et al. A comparison of the repetitive click and conditioning-testing P50 paradigms. Electroencephalogr Clin Neurophysiol 1997;104:157-64.
9. Johnson MR, Adler LE. Transient impairment in P50 auditory sensory gating induced by a cold-pressor test. Biol Psychiatry 1993;33:380-7.
10. White PM, Yee CM. Effects of attentional and stressor manipulations on the P50 gating response. Psychophysiology 1997;34:703-11.
11. Herrmann CS, Knight RT. Mechanisms of human attention: Event-related potentials and oscillations. Neurosci Biobehav Rev 2001;25:465-76.
12. Blomhoff S, Spetalen S, Jacobsen MB, et al. Intestinal reactivity to words with emotional content and brain information processing in irritable bowel syndrome. Dig Dis Sci 2000;45:1160-5.
13. Mayer EA, Craske MG, Naliboff BD. Depression, anxiety and the gastrointestinal system. J Clin Psychiatry 2001;62:28-36.
14. Stam R, Akkermans LMA, Wiegant VM. Trauma and the gut: Interactions between stressful experience and intestinal function. Gut 1997;40:704-9.
15. Thompson WG, Dotevall G, Drossman DA. Irritable bowel syndrome: Guidelines for the diagnosis. Gastroent Int 1989;2:92-5.
16. Beck AT, Epstein N, Brown G, et al. An inventory for measuring clinical anxiety: Psychometric properties. J Consult Clin Psychol 1988;56:893-7.
17. Derogatis LR, Lazarus L. SCL-90-R, Brief Symptom Inventory, and Matching Clinical Rating Scales. Hillsdale, NJ: Lawrence Erlbaum Associates, 1994.
18. Eysenck HJ, Eysenck SBG. Manual of the Eysenck Personality Questionnaire (EPQ-R Adult) Comprising the EPQ-Revised (EPQ-R) and EPQ-R Short Scale. San Diego: Educational and Industrial Testing Service, 1994.
19. Talley NJ, Boyce PM, Jones M. Is the association between irritable bowel syndrome and abuse explained by neuroticism? A population based study. Gut 1998;42:47-53.
20. Gwee KA. The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999;44:400-6.
21. Semlitsch HV, Anderer P, Schuster P, et al. A solution for reliable and valid reduction of ocular artifacts applied to the P300 ERP. Psychophysiology 1986;23:695-703.
22. Chang L, Mayer EA, Johnson T, et al. Differences in somatic perception in female patients with irritable bowel syndrome with and without fibromyalgia. Pain 2000;84:297-307.
23. Mayer EA, Naliboff BD, Chang L, et al. Stress and the gastrointestinal tract: V. Stress and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2001;280:G519-24.
24. Ninomiya H, Onitsuka T, Chen CH, et al. Possible overlapping potentials of the auditory P50 in humans: Factor analysis of middle latency auditory evoked potentials. Electroencephalogr Clin Neurophysiol 1997;104:23-30.
25. Huotilainen M, Winkler I, Alho K, et al. Combined mapping of human auditory EEG and MEG responses. Electroencephalogr Clin Neurophysiol 1998;108:370-9.
26. Weate SJ, Moore JL, Drake ME Jr. Effect of frontal and temporal seizure foci on P50 auditory evoked potentials. Clin Electroencephalogr 1995;26:214-8.
27. Reese NB, Garcia-Rill E, Skinner RD. Auditory input to the pedunculopontine nucleus: I. Evoked potentials. Brain Res Bull 1995;37:257-64.
28. Miyazato H, Skinner RD, Crews T, et al. Serotonergic modulation of the PB midlatency auditory evoked potential in the rat. Brain Res Bull 1999;51:387-91.
29. Miyazato H, Skinner RD, Garcia-Rill E. Neurochemical modulation of the P13 midlatency auditory evoked potential in the rat. Neuroscience 1999;92:911-20.
30. Adler LE, Rose G, Freedman R. Neurophysiological studies of sensory gating in rats: Effects of amphetamine, phencyclidine, and haloperidol. Biol Psychiatry 1986;21:787-98.
31. 2 selective noradrenergic antagonist yohimbine. Biol Psychiatry 1993;33:130-2.
32. Light GA, Malaspina D, Geyer MA, et al. Amphetamine disrupts P50 suppression in normal subjects. Biol Psychiatry 1999;46:990-6.
33. Adler LE, Hoffer L, Nagamoto HT, et al. Yohimbine impairs p50 auditory sensory gating in normal subjects. Neuropsychopharmacology 1994;10:249-57.
34. Valentino RJ, Miselis RR, Pavcovich LA. Pontine regulation of pelvic viscera: Pharmacological target for pelvic visceral dysfunction. Trends Pharmacol Sci 1999;20:253-60.
35. Ladd CO, Huot RL, Thrivikraman KV, et al. Long-term behavioral and neuroendocrine adaptations to adverse early experience. In: Mayer EA, Saper CB, eds. The Biological Basis for Mind Body Interactions. Amsterdam: Elsevier, 2000:81-103.
36. Southwick SM, Bremner JD, Rasmusson A, et al. Role of norepinephrine in the pathophysiology and treatment of post-traumatic stress disorder. Biol Psychiatry 1999;46:1192-204.
37. Lydiard RB, Greenwald S, Weissman MM, et al. Panic disorder and gastrointestinal symptoms: Findings from the NIMH Epidemiologic Catchment Area project. Am J Psychiatry 1994;151:64-70.
38. Wong ML, Kling MA, Munson PJ, et al. Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: Relation to hypercortisolism and corticotropin-releasing hormone. Proc Natl Acad Sci U S A 2000;7:325-30.
39. Mayer EA. The neurobiology of stress and gastrointestinal disease. Gut 2000;47:861-9.
40. Naliboff BD, Derbyshire SWG, Munakata J, et al. Cerebral activation in irritable bowel syndrome patients and control subjects during rectosigmoid stimulation. Psychosom Med 2001;63:365-75.
41. Eysenck HJ. Eysenck on Extraversion. New York: Halsted Press, 1973.